Yarlagadda S. Babu
2016
In 2016, Yarlagadda S. Babu earned a total compensation of $669.2K as Senior Vice President of at BioCryst Pharmaceuticals, a 48% decrease compared to previous year.
Compensation breakdown
| Option Awards | $282,798 |
|---|---|
| Salary | $373,152 |
| Other | $13,250 |
| Total | $669,200 |
Babu received $373.2K in salary, accounting for 56% of the total pay in 2016.
Babu also received $282.8K in option awards and $13.3K in other compensation.
Rankings
In 2016, Yarlagadda S. Babu's compensation ranked 10,089th out of 14,075 executives tracked by ExecPay. In other words, Babu earned more than 28.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,089 out of 14,075 | 28th |
Division Manufacturing | 3,899 out of 5,489 | 29th |
Major group Chemicals And Allied Products | 1,375 out of 1,895 | 27th |
Industry group Drugs | 1,100 out of 1,538 | 29th |
Industry Biological Products, Except Diagnostic Substances | 191 out of 279 | 32nd |
Source: SEC filing on April 12, 2017.
Babu's colleagues
We found four more compensation records of executives who worked with Yarlagadda S. Babu at BioCryst Pharmaceuticals in 2016.
2016
Jon Stonehouse
BioCryst Pharmaceuticals
Chief Executive Officer
2016
William Sheridan
BioCryst Pharmaceuticals
Chief Medical Officer
2016
Thomas Staab
BioCryst Pharmaceuticals
Chief Financial Officer
2016
Lynne Powell
BioCryst Pharmaceuticals